DiviDrip · MYGN

MYGN — Myriad Genetics, Inc.

MYGN is Myriad Genetics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $3.19. Market cap: $305M. Capital Quality Rank: 17/100 — Capital destroyer.

Stock snapshot

Price$3.19
Market cap$305M
SectorHealthcare
ExchangeNMS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)17 / 100 · Capital destroyer
ROIC (TTM)-90.4%
Revenue CAGR (3y)6.7%
Shareholder buyback yield-2.16%
Altman Z-score zoneDistress

About MYGN

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Listed1995Employees2.7KHQSalt Lake City, UTSectorHealthcareWebsitemyriad.com

Related non-dividend companies

Other non-dividend stocks investors research alongside MYGN. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is MYGN's current stock price?

MYGN (Myriad Genetics, Inc.) is currently trading at $3.19.

Does MYGN pay a dividend?

MYGN (Myriad Genetics, Inc.) does not currently pay a regular dividend.

What is MYGN's Capital Quality Rank?

MYGN has a Capital Quality Rank of 17/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track MYGN in DiviDrip

Add MYGN to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-07. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow